|
J Biol Chem, Vol. 275, Issue 2, 847-854, January 14, 2000
Transcription of the Human c-Src Promoter Is Dependent on Sp1, a
Novel Pyrimidine Binding Factor SPy, and Can Be Inhibited by
Triplex-forming Oligonucleotides*
Shawn
Ritchie ,
F. Mark
Boyd,
Jason
Wong, and
Keith
Bonham§
From the Saskatoon Cancer Center Research Unit, Saskatchewan Cancer
Agency. Division of Oncology and Department of
Biochemistry, University of Saskatchewan, Saskatoon,
Saskatchewan S7N 4H4, Canada
The tyrosine kinase
pp60c-src has been implicated in the
regulation of numerous normal physiological processes as well the
development of several human cancers. However, the mechanisms
regulating its expression have not been addressed. In the present
study, we report the presence of two Sp1/Sp3 binding sites and three
polypurine:polypyrimidine (Pu:Py) tracts in the c-Src promoter that are
essential for controlling expression. We demonstrate that Sp1, but not
Sp3, is capable of activating the c-Src promoter and that Sp3 is also
capable of inhibiting Sp1-mediated transactivation. The presence of
multiple Pu:Py tracts conferred S1 sensitivity on plasmids in
vitro, suggesting they are capable of adopting non B-DNA
conformations. These tracts specifically bind a nuclear factor we named
SPy (Src pyrimidine binding factor), which
demonstrates both novel double- and single-stranded binding
specificities. Mutations eliminating SPy binding compromised Src
transcriptional activity, especially in concert with additional mutations affecting Sp1 binding, suggesting the two factors may cooperate in regulating c-Src expression. Finally, we demonstrate that
triplex-forming oligonucleotides designed to target both Sp1 and SPy
binding sites can down-regulate c-Src expression in vitro,
suggesting a potential therapeutic approach to controlling c-Src
expression in diseases where aberrant expression or activity has been documented.
*
This work was supported by grants from the Medical Research
Council of Canada (to K. B.), the Health Services Utilization Research Commission, Saskatchewan, and the University of Saskatchewan College of Medicine scholarship program (to S. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Saskatoon Cancer Center
Research Unit, Saskatchewan Cancer Agency, Div. of Oncology, University
of Saskatchewan, 20 Campus Dr., Saskatoon, Saskatchewan S7N 4H4,
Canada. Tel.: 306-655-2313; Fax: 306-655-2910; E-mail: kbonham@scf.sk.ca.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Gao, A. Howard, K. Ban, and J. Chandra
Oxidative Stress Promotes Transcriptional Up-regulation of Fyn in BCR-ABL1-expressing Cells
J. Biol. Chem.,
March 13, 2009;
284(11):
7114 - 7125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Cen, H. Li, and I. B. Weinstein
Histidine Triad Nucleotide-binding Protein 1 Up-regulates Cellular Levels of p27KIP1 by Targeting ScfSKP2 Ubiquitin Ligase and Src
J. Biol. Chem.,
February 20, 2009;
284(8):
5265 - 5276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. McBride, A. Gazumyan, E. M. Woo, V. M. Barreto, D. F. Robbiani, B. T. Chait, and M. C. Nussenzweig
Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation
PNAS,
June 6, 2006;
103(23):
8798 - 8803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sun, K. Guo, J. J. Rusche, and L. H. Hurley
Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents
Nucleic Acids Res.,
October 20, 2005;
33(18):
6070 - 6080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Dehm, T. L. Hilton, E. H. Wang, and K. Bonham
SRC Proximal and Core Promoter Elements Dictate TAF1 Dependence and Transcriptional Repression by Histone Deacetylase Inhibitors
Mol. Cell. Biol.,
March 15, 2004;
24(6):
2296 - 2307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wei, L. Wang, Y. He, H. Q. Xiong, J. L. Abbruzzese, and K. Xie
Celecoxib Inhibits Vascular Endothelial Growth Factor Expression in and Reduces Angiogenesis and Metastasis of Human Pancreatic Cancer via Suppression of Sp1 Transcription Factor Activity
Cancer Res.,
March 15, 2004;
64(6):
2030 - 2038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bowmaker, M. Y. Yang, T. Yasukawa, A. Reyes, H. T. Jacobs, J. A. Huberman, and I. J. Holt
Mammalian Mitochondrial DNA Replicates Bidirectionally from an Initiation Zone
J. Biol. Chem.,
December 19, 2003;
278(51):
50961 - 50969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. Uil, H. J. Haisma, and M. G. Rots
Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities
Nucleic Acids Res.,
November 1, 2003;
31(21):
6064 - 6078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Schewe, J. H. Leupold, D. D. Boyd, E. R. Lengyel, H. Wang, K. U. Gruetzner, F. W. Schildberg, K. W. Jauch, and H. Allgayer
Tumor-specific Transcription Factor Binding to an Activator Protein-2/Sp1 Element of the Urokinase-type Plasminogen Activator Receptor Promoter in a First Large Series of Resected Gastrointestinal Cancers
Clin. Cancer Res.,
June 1, 2003;
9(6):
2267 - 2276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Ritchie, M. K. Pasha, D. J. P. Batten, R. K. Sharma, D. J. H. Olson, A. R. S. Ross, and K. Bonham
Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcription
Nucleic Acids Res.,
March 1, 2003;
31(5):
1502 - 1513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Carbone, E. M. McGuffie, A. Collier, and C. V. Catapano
Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide
Nucleic Acids Res.,
February 1, 2003;
31(3):
833 - 843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Rao, S. Maiti, H. N. Ananthaswamy, and M. F. Wilkinson
A Highly Active Homeobox Gene Promoter Regulated by Ets and Sp1 Family Members in Normal Granulosa Cells and Diverse Tumor Cell Types
J. Biol. Chem.,
July 12, 2002;
277(29):
26036 - 26045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. DIVIACCO, V. RAPOZZI, L. XODO, C. HELENE, F. QUADRIFOGLIO, and C. GIOVANNANGELI
Site-directed inhibition of DNA replication by triple helix formation
FASEB J,
December 1, 2001;
15(14):
2660 - 2668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Aich, T. J. Thomas, and J. S. Lee
The role of polyamines, Na+ and K+ in the formation of triple helices between purine oligonucleotides and the promoter region of the human c-src proto-oncogene
Nucleic Acids Res.,
June 15, 2000;
28(12):
2307 - 2310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Ko and H. H. Loh
Single-stranded DNA-binding Complex Involved in Transcriptional Regulation of Mouse {micro}-Opioid Receptor Gene
J. Biol. Chem.,
January 5, 2001;
276(1):
788 - 795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bonham, S. A. Ritchie, S. M. Dehm, K. Snyder, and F. M. Boyd
An Alternative, Human SRC Promoter and Its Regulation by Hepatic Nuclear Factor-1alpha
J. Biol. Chem.,
November 22, 2000;
275(48):
37604 - 37611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yang, C. K. Hwang, E. Junn, G. Lee, and M. M. Mouradian
ZIC2 and Sp3 Repress Sp1-induced Activation of the Human D1ADopamine Receptor Gene
J. Biol. Chem.,
December 1, 2000;
275(49):
38863 - 38869.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|